Article: Sepracor Inc. and Eisai Co. Ltd. Announce Partnership for Development and Commercialization of LUNESTA(R) in Japan.

Article: Eisai Enters into In-licensing Agreement with ...
JCN Newswires;  July 27, 2007 ;     700+ words ... ... 2007 - (JCN Newswire) - Eisai Co., Ltd. and Sepracor Inc. signed an in-licensing ... product portfolio. About Sepracor Inc. Headquarters: Marlborough ... 600 Company website: www.sepracor.com About Eisai Co., Ltd. Eisai Co ...

Article: Sepracor and Eisai to sell eszopiclone in ...
Pharma Marketletter;  August 6, 2007 ;     622 words ... ... pharmaceutical company Sepracor has signed an agreement with Japanese drugmaker Eisai that will focus on the ... were not made public, Eisai will be responsible for ... successfully commercialized. Sepracor, which is entitled to ... sales, predicted that Eisai would file for Japanese ...

Article: Amgen Posts Lower Aranesp Sales; Sepracor Shares ...
BIOWORLD Today;  November 3, 2009 ;     700+ words ... ... In other earnings news: o Sepracor Inc., of Marlborough, Mass ... Lunesta, eszopiclone). And Sepracor entered an agreement with Eisai Co. Ltd., of Tokyo, on ... eszopiclone for the Japanese market. Sepracor is entitled to an initial payment ...

Article: Sepracor, GSK Enter $155M Deal Covering Global Lunesta ...
BIOWORLD Today;  September 12, 2007 ;     700+ words ... ... except the U.S., where Sepracor already sells the product; Japan, where Eisai Co. Ltd. licensed rights ... supplying product to GSK. Sepracor said approval in Europe ... deal with Tokyo-based Eisai covering Japan included ... and royalties, with Sepracor targeting approval there ...

Article: Sepracor Inc. Announces Second Quarter 2007 Results and ...
Business Wire;  July 27, 2007 ;     700+ words ... ... Established partnership with Eisai Co. Ltd. for development ... MARLBOROUGH, Mass. -- Sepracor Inc. (Nasdaq: SEPR ... quarter was challenging for Sepracor as we balanced regulatory ... Executive Officer of Sepracor. "This is evidenced ... announced partnership with Eisai for expansion of our ...

Article: Sepracor Sales Force Sweetens Dainippon's $2.6B Buyout ...
BIOWORLD Today;  September 4, 2009 ;     700+ words ... ... week about an acquisition of Sepracor Inc. by Dainippon Sumitomo ... about $2.6 billion, for Sepracor. The deal, which is expected ... Millennium Pharmaceuticals Inc., Eisai Co. Ltd.'s $3.9 billion ... represents a 48 percent premium to Sepracor's average stock price over ...

Article: Sepracor reportedly a buyout target ; Offer of $2.7b ...
The Boston Globe;  September 3, 2009 ;     700+ words ... ... knowledge of the situation." Sepracor's stock jumped 26 percent ... an offer and ends up owning Sepracor, Dainippon Sumitomo would ... biotechnology industry. And Eisai bought MGI Pharma Inc. of ... interested in getting access to Sepracor's US sales force. In June ...